| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.376 | 0.004 | 0.376 | Interleukin 2 antagonist | |||
| 0.413 | 0.07 | 0.413 | 5 Hydroxytryptamine release inhibitor | 0.347 0.118 CID_154699626 | ||
| 0.285 | 0.042 | 0.285 | Sigma receptor agonist | 0.229 0.053 CID_154699626 | ||
| 0.291 | 0.05 | 0.291 | Interleukin antagonist | |||
| 0.277 | 0.042 | 0.304 | Peroxidase inhibitor | 0.304 0.036 CID_154699626 | CID_154699626 | |
| 0.24 | 0.006 | 0.24 | 5 Hydroxytryptamine 3A agonist | 0.192 0.018 CID_154699626 | ||
| 0.284 | 0.054 | 0.284 | 5 Hydroxytryptamine uptake stimulant | 0.193 0.166 CID_154699626 | ||
| 0.252 | 0.059 | 0.252 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.233 0.069 CID_154699626 | ||
| 0.346 | 0.156 | 0.381 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.381 0.118 CID_154699626 | CID_154699626 | |
| 0.246 | 0.06 | 0.246 | Neuropeptide Y2 antagonist | 0.194 0.131 CID_154699626 | ||
| 0.203 | 0.022 | 0.28 | Ferrochelatase inhibitor | 0.28 0.009 CID_154699626 | CID_154699626 | |
| 0.209 | 0.03 | 0.291 | Hexokinase inhibitor | 0.291 0.012 CID_154699626 | CID_154699626 | |
| 0.175 | 0.034 | 0.175 | Neuropeptide Y1 antagonist | 0.122 0.118 CID_154699626 | ||
| 0.185 | 0.051 | 0.185 | ATPase inhibitor | 0.155 0.093 CID_154699626 | ||
| 0.248 | 0.12 | 0.249 | Interleukin 2 agonist | 0.249 0.119 CID_154699626 | CID_154699626 | |
| 0.221 | 0.095 | 0.229 | Hypoglycemic | 0.229 0.09 CID_154699626 | CID_154699626 | |
| 0.14 | 0.017 | 0.14 | CXC chemokine 4 receptor antagonist | 0.076 0.033 CID_154699626 | ||
| 0.199 | 0.091 | 0.199 | Nitric-oxide synthase stimulant | 0.19 0.106 CID_154699626 | ||
| 0.136 | 0.031 | 0.136 | Urease inhibitor | 0.106 0.061 CID_154699626 | ||
| 0.133 | 0.031 | 0.133 | Nitric-oxide synthase inhibitor | 0.091 0.076 CID_154699626 | ||
| 0.186 | 0.091 | 0.186 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.116 | 0.024 | 0.116 | Glutamate release inhibitor | 0.1 0.042 CID_154699626 | ||
| 0.136 | 0.044 | 0.136 | Interleukin 8 antagonist | 0.11 0.076 CID_154699626 | ||
| 0.13 | 0.045 | 0.13 | EphA2 antagonist | 0.102 0.073 CID_154699626 | ||
| 0.127 | 0.044 | 0.127 | Check point kinase 2 inhibitor | |||
| 0.119 | 0.039 | 0.119 | Factor V inhibitor | 0.099 0.071 CID_154699626 | ||
| 0.093 | 0.018 | 0.093 | Urokinase inhibitor | 0.062 0.027 CID_154699626 | ||
| 0.17 | 0.101 | 0.17 | Growth factor agonist | |||
| 0.099 | 0.03 | 0.114 | D-Ala-D-Ala ligase inhibitor | 0.114 0.017 CID_154699626 | CID_154699626 | |
| 0.161 | 0.093 | 0.2 | Succinate dehydrogenase inhibitor | 0.2 0.049 CID_154699626 | CID_154699626 | |
| 0.074 | 0.01 | 0.074 | Potassium channel (Inward rectifier) activator | |||
| 0.086 | 0.023 | 0.086 | 5 Hydroxytryptamine 3 agonist | 0.06 0.049 CID_154699626 | ||
| 0.071 | 0.009 | 0.071 | Potassium channel (ATP-sensitive) activator | |||
| 0.19 | 0.13 | 0.19 | 5 Hydroxytryptamine release stimulant | |||
| 0.104 | 0.044 | 0.104 | Potassium channel activator | |||
| 0.131 | 0.072 | 0.131 | Nav1.2 sodium channel blocker | 0.111 0.094 CID_154699626 | ||
| 0.08 | 0.025 | 0.08 | NMDA 2C receptor antagonist | 0.065 0.039 CID_154699626 | ||
| 0.125 | 0.07 | 0.125 | Cathepsin H inhibitor | |||
| 0.077 | 0.027 | 0.077 | Plasminogen activator inhibitor | |||
| 0.058 | 0.009 | 0.058 | Potassium channel Kv1.1 blocker | |||
| 0.078 | 0.03 | 0.078 | Potassium channel (ATP-sensitive) blocker | |||
| 0.055 | 0.008 | 0.055 | Endothelial nitric-oxide synthase inhibitor | 0.028 0.026 CID_154699626 | ||
| 0.053 | 0.008 | 0.053 | Complement C5a chemotactic receptor antagonist | 0.029 0.021 CID_154699626 | ||
| 0.094 | 0.051 | 0.095 | NADH dehydrogenase inhibitor | 0.095 0.05 CID_154699626 | CID_154699626 | |
| 0.223 | 0.18 | 0.223 | GABA C receptor rho-3 antagonist | 0.213 0.192 CID_154699626 | ||
| 0.084 | 0.042 | 0.084 | Telomerase inhibitor | 0.067 0.055 CID_154699626 | ||
| 0.063 | 0.023 | 0.063 | H+/K+-transporting ATPase inhibitor | 0.062 0.023 CID_154699626 | ||
| 0.066 | 0.026 | 0.066 | NMDA 2A receptor antagonist | 0.052 0.036 CID_154699626 | ||
| 0.08 | 0.042 | 0.08 | Histidine decarboxylase inhibitor | 0.078 0.044 CID_154699626 | ||
| 0.213 | 0.176 | 0.213 | Calpain 2 inhibitor | |||
| 0.071 | 0.035 | 0.077 | NMDA receptor glycine site agonist | 0.077 0.031 CID_154699626 | CID_154699626 | |
| 0.074 | 0.039 | 0.074 | Opioid delta receptor antagonist | |||
| 0.069 | 0.034 | 0.069 | Neuraminidase inhibitor | 0.061 0.042 CID_154699626 | ||
| 0.062 | 0.029 | 0.062 | Sphingosine kinase 2 inhibitor | |||
| 0.051 | 0.018 | 0.051 | Dihydrofolate reductase inhibitor | 0.041 0.036 CID_154699626 | ||
| 0.069 | 0.037 | 0.069 | Neuraminidase (influenza) inhibitor | 0.064 0.044 CID_154699626 | ||
| 0.069 | 0.037 | 0.069 | NMDA receptor agonist | 0.066 0.04 CID_154699626 | ||
| 0.084 | 0.052 | 0.084 | Opioid kappa receptor antagonist | |||
| 0.089 | 0.058 | 0.089 | Opioid antagonist | |||
| 0.044 | 0.012 | 0.044 | Bradykinin B2 receptor antagonist | |||
| 0.058 | 0.028 | 0.058 | Protease activated receptor 1 antagonist | |||
| 0.059 | 0.03 | 0.059 | Epithelial sodium channel blocker | |||
| 0.064 | 0.036 | 0.064 | Neuropeptide agonist | |||
| 0.041 | 0.014 | 0.041 | Tryptophan 5 hydroxylase inhibitor | 0.037 0.021 CID_154699626 | ||
| 0.083 | 0.057 | 0.083 | Inducible nitric-oxide synthase inhibitor | |||
| 0.052 | 0.027 | 0.052 | Melanocortin antagonist | |||
| 0.047 | 0.025 | 0.047 | Melanocortin 4 antagonist | |||
| 0.173 | 0.151 | 0.173 | Superoxide dismutase inhibitor | |||
| 0.094 | 0.074 | 0.094 | Nav1.1 sodium channel blocker | |||
| 0.056 | 0.037 | 0.056 | Cathepsin D inhibitor | |||
| 0.142 | 0.123 | 0.142 | Neurotensin receptor agonist | |||
| 0.09 | 0.072 | 0.09 | Aminopeptidase B inhibitor | |||
| 0.142 | 0.124 | 0.142 | Phospholipase C inhibitor | 0.142 0.125 CID_154699626 | ||
| 0.057 | 0.041 | 0.057 | Botulinum neurotoxin type A inhibitor | |||
| 0.028 | 0.013 | 0.028 | Complement factor 1r inhibitor | 0.025 0.019 CID_154699626 | ||
| 0.021 | 0.007 | 0.021 | Potassium channel (Inward rectifier) 11 blocker | 0.021 0.008 CID_154699626 | ||
| 0.067 | 0.054 | 0.067 | CXC chemokine receptor antagonist | |||
| 0.055 | 0.042 | 0.055 | Kallikrein 1 inhibitor | |||
| 0.03 | 0.018 | 0.03 | Thrombin receptor antagonist | |||
| 0.07 | 0.059 | 0.07 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.166 | 0.155 | 0.167 | Peptidyltransferase inhibitor | 0.167 0.154 CID_154699626 | CID_154699626 | |
| 0.019 | 0.009 | 0.019 | Tryptophan hydroxylase 1 inhibitor | 0.017 0.013 CID_154699626 | ||
| 0.083 | 0.075 | 0.083 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.057 | 0.053 | 0.057 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.059 | 0.055 | 0.059 | Opioid mu receptor antagonist | |||
| 0.029 | 0.025 | 0.029 | Potassium channel small-conductance Ca-activated activator | |||
| 0.185 | 0.181 | 0.185 | Insulysin inhibitor | |||
| 0.038 | 0.034 | 0.038 | Complement C3a chemotactic receptor antagonist | |||
| 0.084 | 0.08 | 0.084 | MAP kinase kinase 1 inhibitor | |||
| 0.047 | 0.044 | 0.047 | CXC chemokine 1 receptor antagonist | |||
| 0.039 | 0.036 | 0.039 | Histamine H2 receptor agonist | |||
| 0.041 | 0.039 | 0.041 | Histamine H1 receptor agonist | |||
| 0.159 | 0.158 | 0.159 | Interleukin agonist | |||
| 0.086 | 0.096 | 0.093 | Cystathionine beta-synthase inhibitor | 0.093 0.085 CID_154699626 | CID_154699626 | |
| 0.036 | 0.048 | 0.042 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.042 0.028 CID_154699626 | CID_154699626 | |
| 0.079 | 0.099 | 0.115 | Electrolyte absorption antagonist | 0.115 0.041 CID_154699626 | CID_154699626 | |
| 0.146 | 0.169 | 0.169 | MAP kinase kinase 5 inhibitor | 0.169 0.088 CID_154699626 | CID_154699626 | |
| 0.066 | 0.106 | 0.087 | HIV-1 integrase (Overall Integration) inhibitor | 0.087 0.069 CID_154699626 | CID_154699626 | |
| 0.067 | 0.122 | 0.089 | GABA C receptor agonist | 0.089 0.08 CID_154699626 | CID_154699626 | |
| 0.106 | 0.171 | 0.12 | Death-associated protein kinase 1 inhibitor | 0.12 0.112 CID_154699626 | CID_154699626 | |
| 0.11 | 0.235 | 0.15 | Death-associated protein kinase 2 inhibitor | 0.15 0.107 CID_154699626 | CID_154699626 | |
| 0.152 | 0.319 | 0.201 | MAP kinase kinase 3 inhibitor | 0.201 0.12 CID_154699626 | CID_154699626 | |
| 0.003 | 0.314 | 0.097 | Integrin beta7 antagonist | 0.097 0.004 CID_154699626 | CID_154699626 | |
| 0.005 | 0.878 | 0.11 | Chelator | 0.11 0.064 CID_154699626 | CID_154699626 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |